Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of osteoarthritis (OA), rheumatoid arthritis (RA), and juvenile idiopathic arthritis (JRA) in patients with a body weight of ≥ 60 kg.
How to Purchase Meloxicam
Overseas Purchase
Patients may choose to consult and purchase Meloxicam at hospital pharmacies or licensed drugstores in countries/regions where the medication has been launched.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase Through Medical Service Institutions
Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions usually provide legal import channels and can offer professional consultation and guidance.
Precautions for Purchase and Use of Meloxicam
Features of Authentic Packaging
Meloxicam has clear packaging and specification characteristics:
The 7.5 mg tablets are pale yellow, round, biconvex, and uncoated. One side is embossed with the Boehringer Ingelheim logo, and the other side is embossed with the letter "M".
The 5 mg tablets are pale yellow, oval, biconvex, and uncoated. One side is embossed with the tablet code "15", and the other side is embossed with the letter "M".
Drug Label Information
Authentic Meloxicam product packaging must contain complete drug information, including: generic name, brand name, specification, batch number, expiration date, and manufacturer information.
Strict Contraindications
Perioperative period of coronary artery bypass grafting (CABG): Use is prohibited.
Patients allergic to aspirin: Prohibited in patients with a history of asthma, urticaria, or other allergic reactions.
Medication Warnings for High-Risk Populations
Cardiovascular risk: Elderly patients and those with a history of cardiovascular and cerebrovascular diseases should use Meloxicam with caution, as thrombotic events may occur at the initial stage of treatment.
Pregnant women: Use after 20 weeks of gestation may cause fetal renal damage and oligohydramnios; use after 30 weeks of gestation increases the risk of premature closure of the ductus arteriosus.
Patients with hepatic or renal impairment: Avoid use in patients with severe hepatic impairment (Child-Pugh Class C) and severe renal impairment.
Management of Drug Interactions
Anticoagulants (e.g., warfarin) and antiplatelet drugs (e.g., aspirin): Concomitant use may increase the risk of bleeding; close monitoring of bleeding signs is required.
Antihypertensive drugs (ACEIs/ARBs/β-blockers): NSAIDs may weaken their antihypertensive effect.
How to Identify Authenticity of Meloxicam
Verification of Packaging and Appearance
7.5 mg tablets: Round, pale yellow; one side embossed with the Boehringer Ingelheim trademark, and the other side with the letter "M".
Verification of Official Information
Verify the product batch number, expiration date, and NDC (National Drug Code) through the anti-counterfeiting inquiry system of the manufacturer (Boehringer Ingelheim).
